- 製品詳細
- データ表示
- Reviews & Citations
- Resources

To speed up in-process and lot-release sterility testing, the Sterility Rapid Detection Kit (based on NAT) is developed and validated to meet European Pharmacopeia Chapter 2.6.1 and USP General Chapter <71> requirements.
Its key advantage is integrated detection: paired with the SAFENSURE™ Sterility Sample Preparation Kit (OPA-E102), it sensitively and reliably detects bacteria and fungi simultaneously in biological products, pharmaceuticals, and medical devices—no separate qPCR assays needed. This avoids split-sample handling and repeated operations, reducing error risks.
Meeting strict sterility testing regulations (no detectable viable microorganisms), it replaces traditional 14-day culture-based methods. Even with dual detection, it delivers accurate results in just 3 hours, boosting product release efficiency and cutting testing time/labor costs.
The kit is used for detection of bacteria or fungus contamination in cells and bioproduct media.
For use in quality control/manufacturing process only.
It is for research use only.

If your experimental workflow involves host cell DNA sample preparation, please use the recommended sample preparation kits listed in the table. This ensures that the buffers used during both sample preparation and residual DNA quantitation remain consistent, supporting reliable and accurate results.

ID | Components | Size |
OPA-S103-01 | Sterility Assay Mix | 200 μL |
OPA-S103-02 | Sterility qPCR Master Mix | 400 μL |
OPA-S103-03 | Sterility Positive Control | 500 μL |
OPA-S103-04 | Sterility Internal Control | 200 μL |
OPA-S103-05 | DNase/RNase-Free Water | 1 mL |